Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Amit Misra

6PUBLICATIONS
1CO-AUTHORS
Powder and particle technologyPharmaceutical delivery technologiesPharmacogenomicsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Feb 04, 2025
Dry Powder Inhalation of Nintedanib in Dibasic Calcium Phosphate for Targeting the Lungs in Pulmonary Fibrosis.

Sanjay Singh, Frinto Francis, Mohit Barsain

|Oct 17, 2024
Comparative Preclinical Pharmacokinetics and Disposition of Favipiravir Following Pulmonary and Oral Administration as Potential Adjunct Therapy Against Airborne RNA Viruses.

Venkata Siva Reddy Devireddy, Hasham Shafi, Sonia Verma

|Jun 08, 2023
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.

Sonia Verma, Nils-Jorgen K Dal, Ashish Srivastava

|Aug 12, 2022
Preparation and Evaluation of Low-Dose Calcitriol Dry Powder Inhalation as Host-Directed Adjunct Therapy for Tuberculosis.

D V Siva Reddy, Hasham Shafi, Reena Bharti

|Apr 10, 2019
Preclinical Development of Inhalable d-Cycloserine and Ethionamide To Overcome Pharmacokinetic Interaction and Enhance Efficacy against <i>Mycobacterium tuberculosis</i>.

Rajeev Ranjan, Ashish Srivastava, Reena Bharti

|Mar 07, 2017
Pharmacokinetics, Metabolism, and Partial Biodistribution of "Pincer Therapeutic" Nitazoxanide in Mice following Pulmonary Delivery of Inhalable Particles.

Anuradha Gupta, Sachin L Tulsankar, Rabi S Bhatta

Pageof 1

Frequent Collaborators

1 joint publications

Himanshu Bansode

Frequent Collaborators

1 joint publications

Himanshu Bansode

Top Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on : May 09, 2025

154
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or  <em>A. baumannii</em>
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

14.6K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

Published on : Mar 24, 2017

7.9K
See more related videos

Top Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on : May 09, 2025

154
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or  <em>A. baumannii</em>
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

14.6K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

Published on : Mar 24, 2017

7.9K
See more related videos